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The aim of the current investigation is to evaluate the transdermal potential of 
novel vesicular carrier, ethosomes, bearing aceclofenac, Non-steroidal anti-
inflammatory drugs (NSAIDs) agents having limited transdermal permeation. 
Aceclofenac loaded ethosomal carriers were prepared, optimized and 
characterized for vesicular shape and surface morphology,(SEM) scanning 
electronic microscopy, vesicular size, entrapment efficiency, stability, in- 
vitro release study. The formulation (Etho5) having 3% phospholipids 
contant and 40% ethanol showing the grater entrapment (93.3%) and optimal 
average vesicle size of formulation (Etho5) determine by Malvern Zetamaster 
ZEM & 0.696µm and zeta potential of formulation was -6.74 mV. The 
formulation (Etho12) having 3% phospholipids contant and 40% isopropyl 
alcohol showing the grater entrapment (95.7%). stability profile of prepared 
system assessed for 45 days. The vesicular suspension was kept in sealed 
vials (10ml) at 4 ± 2ºC and at room temperature for 45 days no change is 
shown in the entrapment efficiency. The optimized ethosomal formulation 
showed transdermal flux (226.1 µg/cm²/hr) for ethanolic drug solution which 
is grater then that of isopropyl alcohol solution (159.0 µg/cm²/hr). The result 
advocates the potential of ethosome formulation to treat rheumatic disease 
where facilitated penetration of the drug into muscle and synovial fluid is 
desirable. In light of the data obtained from experimental work we can expect 
the ethosome formulation to be safe and very efficient as a drug carrier for 
systemic as well as topical delivery of drug, holding future in effective 
transdermal delivery.  
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Introduction  
Ethosomes are interesting and innovative vesicular 
systems that have appeared in the field of 
pharmaceutical technology and drug delivery in recent 
years. This carrier presents interesting features 
correlated with its ability to permeate intact through the 
human skin due to its high deformability. Ethosomes 
are  soft,   malleable  vesicles   tailored   for    enhanced  
 
 
delivery of active agents. It has been shown that the 
physicochemical characteristics of ethosomes allow 
this vesicular carrier to transport active substances 
more efficaciously through the stratum corneum into 
the deeper layers of the skin than conventional 
liposomes . This aspect is of great importance for the 
design   of   carriers  to  be  applied  topically  both  for  
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topical and systemic drug administration [1]. The skin 
acts as a major target as well as a principle barrier for 
topical/transdermal (TT) drug delivery. The stratum 
corneum plays a crucial role in barrier function for TT 
drug delivery. Despite major research and development 
efforts in TT systems and the advantages of these 
routes, low stratum corneum permeability limits the 
usefulness of topical drug delivery. To overcome this, 
methods have been assessed to increase permeation. 
One controversial method is the use of vesicular 
systems, such as liposomes, ethosomes and niosomes, 
whose effectiveness depends on their physicochemical 
properties. 
Nonsteroidal anti-inflammatory drugs (NSAIDs) are 
the most commonly used drugs to reduce pain and 
inflammation. Aceclofenac, an NSAID, has been 
recommended orally for the treatment of rheumatoid 
arthritis and osteoarthritis. It also has anti-
inflammatory, antipyretic, and analgesic activities. The 
short biological half-life (about 4 h) and a higher 
dosing frequency make aceclofenac an ideal candidate 
for sustained release.The oral administration of 
aceclofenac causes gastrointestinal ulcers and 
gastrointestinal bleeding with chronic use. Because of 
gastrointestinal bleeding, it also causes anemia. Using 
the transdermal route eliminates these side effects, 
increases patient compliance, avoids first-pass 
metabolism, and maintains the plasma drug level for a 
longer period of time. Therefore, an improved 
aceclofenac formulation with a high degree of 
permeation could be useful in the treatment of locally 
inflamed skin and inflammatory and painful states of 
supporting structures of the body. 
Touitou discovered lipid vesicular systems ethosomes 
embodying ethanol in relatively high concentration. 
Ethosomes contain phospholipids, alcohol (ethanol and 
isopropyl alcohol) in relatively high concentration and 
water. Unlike classical liposomes, ethosomes were 
shown to permeate through the stratum corneum barrier 
and were reported to possess significantly higher 
transdermal flux in comparison to liposomes. The exact 
mechanism for better permeation into deeper skin 
layers from ethosomes is still not clear. However, 
synergistic effects of combination of phospholipids and 
high concentration of ethanol in vesicular formulations 
have been suggested to be responsible for deeper 
distribution and penetration in the skin lipid bilayer. 
The use of lipid vesicles as drug delivery systems for 
skin treatment has attracted increasing attention in 
recent years. However, it is generally accepted that 
conventional ethosomes are of little value for this 
purpose. Ethosomes remain confined to the upper layer 
of stratum corneum (SC) and hence, are suitable for 
topical drug delivery. Only specially designed vesicles 
were shown to deliver drugs across the skin layers [1]. 
Hence the aim of present study was to develop 
sustained topical ethosomal gel of aceclofenac and to 
evaluate with respect to various in vitro  evaluation 
tests. Presently no scientific reports are available on the 
formulation of topical drug delivery system of 
ethosomal gel of aceclofenac. Hence, in this study an 
attempt has been made to prepare and evaluate a 
topical drug delivery system of ethosomal gel of 
aceclofenac. 
Material and methods 
Aceclofenac was received as a gift sample from Lupin 
Research Park, Pune, Soya phosphatidyl choline were 
purchased from Sigma-Aldrich Chemie, Germany, 
ethanol, propylene glycol, methanol, choloroform, 
isopropyl alcohol from Qualigens, Mumbai Carbopol 
934k from  S d fine-chemical limited Mumbai, All 
other chemicals used were of analytical grade. 
 
Method of preparation 
Aceclofenac ethosome was prepared as described by 
Touitou et al .The ethosomal system of aceclofenac 
was comprised of 0.5 – 4 % phospholipids, 10 – 50 
%w/w of ethanol, 1 %w/w aceclofenac, 5 % propylene 
glycol and water upto 100 %w/w. Aceclofenac 
ethosomes were prepared using different 
concentrations of lecithin, ethanol, isopropyl alcohol, 
propylene glycol and aceclofenac as given in the (table 
3.4 and 3.5). Phospholipids and drug were dissolved in 
ethanol and propylene glycol. The mixture was heated 
to 30º C in water bath. In this solution distilled water 
was added slowly in a fine stream with a constant 
mixing (Mechanical stirrer, Remi equipment, Mumbai) 
at 700 rpm in a closed vessel. The temperature was 
maintained at 30º C during the experiment. The mixing 
was continued for 5 minutes. The preparation was 
stored at 4º C. Ethosome prepared by the above 
procedure were subjected to sonication at 4ºc using 
probe sonicator in 3 cycles of 5 minutes with 5 minutes 
rest between the cycles [2]. 
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Incorporation into Gel 
Carbopol 934P 0.75% w/v was soaked in minimum 
amount of water for an hour. Ethosomal suspensions 20 
ml containing aceclofenac (200mg) was added to the 
swollen polymer under stirring. Stirring was contained 
were then incorporated in gel with continuous stirring 
at 700 rpm in a closed vessel and maintained at 
temperature  30ºC until homogeneous ethosomal gels 
were achieved. The pH was then adjusted to neutral 
using (TEM) triethanol amine and stirred slowly till a 
gel was obtained. pH measurement of the formulations  
were carried out using pH meter by dipping the glass 
electrode completely into the semisolid formulation so 
as to cover the electrode [3, 4]. 
 
Fourier Transform Infrared Spectroscopy 
Infrared spectroscopy was conducted using a Shimadzu 
FTIR 8300 Spectrophotometer and the spectrum was 
recorded in the region of 4000 to 400 cm-1. The 
procedure consisted of dispersing a sample (drug and 
drug-excipient mixture, 1:1 ratio) in KBr (200-400 mg) 
and compressing into discs by applying a pressure of 5 
tons for 5 min in a hydraulic press. The pellet was 
placed in the light path and the spectrum was obtained. 
All spectra were collected as an average of three scans 
at a resolution of 2 cm-1. 
 
 




Etho1 Etho2 Etho3 Etho4 Etho5 Etho6 Etho7 Etho8 Etho9 Etho10 
Drug 1 1 1 1 1 1 1 1 1 1 
Phospholipid 2 2 2 2 3 3 3 3 4 3 
Ethanol 40 35 30 25 40 35 30 25 40 50 
Propylene 
glycol 
1 1 1 1 1 1 1 1 1 1 
Carbopol 934k 0.75 0.75 0.75 0.75 0.75 0.75 0.75 0.75 0.75 0.75 
Water q.s q,s q.s q.s q.s q.s q.s q.s q.s q.s 
Characterization 
%Entrapment 
efficiency 83.0± 3 79.2± 6 77.8± 5 73.8± 6 93.2± 6 91.0± 8 89.5± 1 83.5± 1 90.6± 6 81.6± 9 
Vesicle size - - - - 0.696 - 1.140 - - - 
pH 6.6 - - - 5.7 - 6.2 - - - 
Gel strength ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ 
J (Flux) 198.8 - - - 226.1 - 201.8 - - - 
R (Regression 
coefficient) 
0.9886 - - - 0.9464 - 0.991 - - - 
 
Differential Scanning Calorimetry 
Differential scanning calorimetry was performed by 
using DSC-60. The instrument comprised of 
calorimeter (DSC 60), flow controller (FCL 60), 
Thermal analyzer (TA 60) and operating software TA 
60 from (Shimadzu Corporation, Japan.) The samples 




followed by heating under nitrogen flow (30 ml/min) at 
a   scanning   rate   of  5oC/min  from  25oC  to  200oC.  
Aluminium pan containing same quantity of indium 
was used as reference. The heat flow as a function of 
temperature was measured for both the drug and drug-
excipient mixture.  
 
 
Dave et al. International Journal of Drug Delivery 2 (2010) 81-92 
 
 84
Optical Microscope Observation 
The ethosomal dispersion was spread on the glass slide 
using a glass rod. Formation of multilamellar vesicles 
was confirmed by examining the ethosomal suspension 
under an optical microscope with the magnification 
power of 100 x. (Olympus CX41, Philippines) 
Photographs of vesicles were taken using Olympus 
camera. 
 
Table 2. Composition and characteristics of 
ethososmal gel containing IPA 
 
Composition 
in % w/w 
Etho11 Etho12 Etho13 Etho14 
Drug 1 1 1 1 
Phospholipid 2 3 3 3 
Isopropyl 
alcohol 




1 1 1 1 
Carbopol 934k 0.75 0.75 0.75 0.75 
Water q.s q,s q.s q.s 
Characterization 
%Entrapment 
88.01 95.73 84.04 83.82 
Vesicle size - - - - 
pH - 7.2 7.1 7.4
Gel strength ++ ++ ++ ++ 
J (Flux) - 159 - 146
R(Regression 
ffi i )




(a)Vesicle size and size distribution 
The vesicle size, size distribution and zeta potential of 
optimized ethosomes formulation were determine by 
the dynamic light scattering (DLS) using a 
computerized inspection system (Malvern Zetamaster 
(ZEM 500962, Malvern, UK). The electric potential of 
ethosome, including its stern layer (ZETA 
POTENTIAL) was determine by injecting the diluted 
system into a zeta potential measurement cell. 
 
(b)Vesicular shape and surface morphology 
Scanning electronic microscopy (SEM) was also 
conducted to characterize the surface morphology of 
the ethosome vesicles were analyzed by scanning 
electron microscopy (SEM). Prior to analysis, the 
ethosome were mounted onto double-sided tape that 
has previously been secured on copper stubs and coated 






















































































































































































































































































Figure1. IR spectra: A) aceclofenac, B) ethosome 7, 
C) ethosome 8 
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Ethosome vesicles were visualized using a Philips 
TEM (transmission electron microscope) CM 12 
electron microscope (TEM, Eindhoven, The 
Netherlands), with an accelerating voltage of 100 kV. 
Samples were negatively stained with a 1% aqueous 
solution of PTA (phosphotungstic acid). Ethosomal 
solution (10 μl) was dried on a microscopic carbon-
coated grid for staining. The excess solution was 
removed by blotting. After drying, the specimen was 
viewed under the microscope at a 10–100 k fold 
enlargement. 
 












































Figure 2. DSC thermogram of A) aceclofenac, 
B)Etho7, C)Etho8. 
Entrapment efficiency 
The entrapment capacity of aceclofenac  ethosomes 
was measured by the ultracentrifuge method .Vesicular 
preparations containing 1% aceclofenac were kept 
overnight at 4˚C and centrifuged in a 
ultracentrifuge(Remi) equipped with TLA-45 rotor at 
4˚C, at 30 000 rpm for 2 h. aceclofenac was assayed 
both in the sediment and in the supernatant. The 
entrapment capacity of aceclofenac was calculated 
from the relationship [(T-C)/T] 100, where T is the 
total amount of aceclofenac that is detected both in the 
supernatant and sediment, and C is the amount of 
aceclofenac detected only in the supernatant [5].  
 
In vitro permeation studies 
The in-vitro skin permeation of aceclofenac from 
ethosomal formulation was studied using locally 
fabricated diffusion cell. The in-vitro diffusion of the 
drug through semipermeable membrane was 
performed. The semi permeable membrane soaked in a 
buffer for 6-8 hours. It was clamped carefully to one 
end of the hollow glass tube of 17 mm (area 2.011 
cm²) (dialysis cell). This acted as donor compartment. 
50 ml of PBS 6.4 was taken in a beaker which was 
used as a receptor compartment. The known quantity 
was spread uniformly on the membrane. The donor 
compartment was kept in contact with the receptor 
compartment and the temperature was maintained at 37 
± 0.1 ºC. The solutions of the receptor side were stirred 
by externally driven Teflon-coated magnetic bars. At 
predetermined time intervals, sample was withdrawn 
and replaced by 3 ml of PBS. The drug concentrations 
in the aliquot were determined at 275 nm against 
appropriate blank. This experiment was done in 
triplicate and average value was reported. In- vitro skin 
permeation studies were conducted for different 
formulation and effect of variation in composition on 
permeation rate Ethanol and phospholipid skin 
permeation from ethosomal systems or isopropyl 
alcohol and phospholipids skin permeation from 
ethosomal system was also studied. 
 
Permeation enhancers 
These are compound, which promote skin permeability 
by altering the skin as a barrier to the flux of a desired 
penetrant.  
The flux, J, of drug across the skin can be written as:  
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                     J = D dc/ dx 
Where D is the diffusion coefficient and is a function 
of the size, shape and flexibility of the diffusing 
molecule as well as the membrane resistance, C is the 
concentration of the diffusing speacies, X is the spatial 
coordinate.  
The in vitro skin permeation of acelecfenac from 
ethosomal formulation was studied using diffusion cell 
specially designed in our laboratory according to the 
literates. The effective permeation area of the diffusion 
cell is 2.011 cm². The temperature was maintained at 





Figure 3. Microscopic images of  aceclofenac 
ethosome (Etho 5) 
 
pH Measurments 
The pH measurements of the formulations were carried 
out using a pH meter by dipping the glass electrode 
completely into the semisolid formulation as to cover 
the electrode showed in (table 1 and 2). 
 
Stability study 
All regulatory bodies accept only real time data for any 
drug or pharmaceutical for all purpose of assessing the 
shelf life and only accelerated stability studies may 
serve as a tool for formulation screening and stability 
issues related to shipping or storage at room 
temperature. The accelerated stability studies were 
carried out in accordance with the ICH guidelines. The 
ability of vesicles to retain the drug was assessed by 
keeping the ethosomal suspension at different 
temperature. Optimized ethosome formulation was 
selected for stability studies of vesicles. The vesicular 
suspension was kept in sealed vials (10ml) at 4 ± 2ºC 
and at room temperature for 45 days. Percent 
entrapment was determined at different time intervals. 
It was observed that the ethosomal system was more 





Figure 4. SEM of ethosome powder formulation 
Etho 5 after liyophilization. 
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Result and discussion 
IR, DSC, SEM studies 
The possible interaction between the drug and the 
excipients were studied by IR spectroscopy and DSC. 
IR spectra of pure aceclofenac, its physical mixture 
with phospholipids and the prepared formulation are 
shown in Fig 1. Pure aceclofenac showed major peaks 
at 3317.3, 2970.2, 2935.5, 1716.5, 1589.2, 1506.3, 
1479.3, 1344.3, 1280.6, 1255.6, and 665.4 cm-1. The 
result revealed no considerable change in the IR peaks 
of aceclofenac in the physical mixture or in the 
prepared crystals when compared to pure drug there by 
indicating the absence of any interaction. 
The results of DSC studies are given in fig.2. Pure 
aceclofenac showed a sharp endotherm at 154.49°C 
corresponding to its melting point/transition 
temperature. There was no appreciable change in the 
melting endotherms of the physical mixture 
(aceclofenac + polymer) compared to pure drug. This 
observation further supports the IR spectroscopy 
results, which indicated the absence of any interactions 
between drug and additives used in the preparation. 
However there was slight decrease in the melting point 
of the drug. It was also observed that there was a 
noticeable reduction in the enthalpy of the formulation 
with compare to aceclofenac formulation (Etho7) 
showed -4.6 j/mg. The lowest melting point was 
153°C. Surface morphology and three-dimensional 
nature of ethosomes were further confirmed by SEM, 
justifying the vesicular characteristics possessed by this 
novel carrier (Fig.4). 
Ethosomal carriers are a system containing soft 
vesicles and are composed mainly of phospholipids 
(phosphatidylcholine PC), ethanol, isopropyl alcohol in 
relative higher concentration and water. The 
compositions of different ethosomal formulation are 
shown in the table1 and 2. Ethosome are soft, 
phospholipids nanovesicles (tiny, bubble-like, lipid 
spheres) which due to their structure, are able to 
overcome the natural dermal barrier, delivering drugs 
through the skin layers. The ethosome delivery system 
can be modulated not only for enhanced skin 
penetration but localizes the drug at the site of action, 
enable drugs to reach the deep skin layers. 
 
Microscope Observation  
The ethosomal dispersion was spread on the glass slide 
using a glass rod. Formation of multilamellar vesicles 
was confirmed by examining the ethosomal suspension 
under an optical microscope with the magnification 
power of 100 x. (Olympus CX41, Philippines) 
Photographs of vesicles were taken using Olympus 
camera. Vesicular size and entrapment efficiency are 
the basic parameter on the basis of which the 
formulations were optimized. The effect of 
phospholipids and ethanol concentration on the size 
distribution of ethosome vesicles was investigated 
using dynamic light scattering (DLS) method. 
Formulation Etho 5 and Etho 7 have same 
concentration of lecithin 3% but ethanol concentration 
is varied. In formulation Etho 5 ethanol concentration 
is 40% and in formulation Etho 7 the ethanol 





































































Figure 5. Percent entrapment of A) Ethanol 
concentration B) Isopropyl alcohol concentration 
 
For ethosome formulation with 40% ethanol and 3% 
phospholipids, the data shows narrow particle size 
distribution with an average vesicles size of 0.696 μm. 
In the ethanol concentration range of 20%-45%, the 
size of the vesicles increase with decreasing the ethanol 
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concentration. It was observed that preparation 
containing 30% ethanol formulation Etho 7 the 
vesicular size is 1.140 µm and the preparation 
containing 40% ethanol formulation Etho 5 the 
vesicular size is 0.696 µm. The size of the vesicles was 
decreased with increasing ethanol concentration. The 
size analysis was done for formulation Etho 5 and Etho 
7 which contain same concentration of phospholipids. 
Hence the effect of phospholipids concentration on size 
could not be explained.The zeta seizer report showed 
that there was less difference in vesicles size. Zeta 
potential of formulation was – 6.74s mv which showed 
that the higher concentration of ethanol make the 
negative charge on vesicles surface. 
These result further supported by the observation of 
methotrexate (MTX) loaded ethosome made by Dubey 
et al [7, 8]. Though with increase in ethanol 
concentration the vesicular size decreased, a 
phenomenon observed by number of scientific groups. 
This indicates that at higher ethanol concentration the 
membrane thickness is reduced considerably, probably 
due to the formation of a phase with interpenetrating 
hydrocarbon chain. Further, an interesting possible 
mechanism given by Lasic et al.; 1998, which state that 
ethanol causes a modification of the net charge of the 
system and confers it some degree of steric 
stabilization that may finally lead to a decrease in the 



























Figure 6. In vitro drug release of aceclofenac from 
Etho 1, 5, 7 and Marketed formulations 
 
Entrapment efficiency 
The entrapment efficiency of ethosomes was 
determined for all formulation. Effect of ethanol 
concentration was observed on percent entrapment of 
ethosomes. The entrapment efficiency was maximum 
for formulation Etho 5 (93.3%) and minimum for 
formulation Etho 4 (74.02%). The entrapment was 
found to increase with increase in ethanol 
concentration, however percent entrapment decreased 
when ethanol concentration exceeded 40 %. Solubility 
of aceclofenac also increased when ethanol was used in 
higher concentration. Therefore, the drug also 
entrapped in the core of the vesicles. But as the 
concentration of ethanol increased above 40 % there 
was leakage of the drug from bilayer of the vesicles. 
The entrapment efficiency increased with an increase 
in concentration of lecithin but, above 3% of lecithin 
concentration there was no significant increase in 
percent entrapment. In formulations Etho 1 to Etho 4, 
2% lecithin was used and the concentration of ethanol 
was varied. Formulation Etho 1 showed maximum 
entrapment efficiency (83%). Formulation Etho4 
showed minimum entrapment efficiency (73.84%) as 
shown in the (Table 1). and bar graph (Fig 5). The 
results showed that as the concentration of ethanol 
increased from 25% to 40% the entrapment efficiency 
increased. In formulations Etho 5 to Etho 8, 3% 
lecithin was used and the concentration of ethanol 
varied. Formulation Etho 5 showed the maximum 
entrapment efficiency (93%). Formulation Etho 8 
showed the minimum entrapment efficiency (83.56%) 
as shown in the (Table 1). and bar graph (Fig 5). The 
results show that as the concentration of ethanol 



























Figure 7. In vitro release of aceclofenac from mouse 
skin 
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However when we compare formulation Etho 1 and 
formulation Etho 5 both have similar ethanol 
concentration 40% but differ in lecithin concentration. 
In formulation Etho 1 the lecithin concentration was 
2% and in formulation Etho 5 the lecithin concentration 
was 3%.It is shown that increase in the lecithin 
concentration increases entrapment. In formulation 
Etho 1 the entrapment was (83%) and in formulation 
Etho 5 the entrapment was (93.2%). 
The entrapment efficiency in formulation Etho 5 to 
Etho 8 was much greater compared to formulation 
Etho1 to Etho4. Formulation Etho 5-8 have 3% lecithin 
where as formulation Etho 1-4 have 2% lecithin. This 
indicates that lecithin play an important role in percent 
entrapment. This was shown in the bar graph.The 
entrapment efficiency increased with an increase in the 
concentration of lecithin but, above 3% lecithin 
concentration there was no significant increase in the 
entrapment efficiency. This is evident from the 
entrapment efficiency of formulation Etho 9 (90%) in 
which 4% lecithin was used. In formulation Etho10 the 
ethanol concentration was 50% but there was no 
increase in the entrapment. Formulation Etho 5 and 
Etho 10 have same composition but differ in the 
ethanol concentration. Increasing the ethanol to 40% 
w/w, increased in the entrapment efficiency and further 
increased in the ethanol concentration (> 40%w/w) the 
vesicle membrane become more permeable that leads 
to decrease in the entrapment efficiency of ethosome 
formulation. In formulation Etho 5 the entrapment was 
(93.3%) and where as in formulation Etho 10 the 
entrapment was low (81.6%). 
Another attempt was made with the help of isopropyl 
alcohol. As such there is no work reporting the effect 
of isopropyl alcohol on entrapment and penetration. 
Formulations of ethosomes were made to compare the 
effect of ethanol and isopropyl alcohol on entrapment 
and permeation. The entrapment efficiency of 
ethosomes was determined for all formulation. Effect 
of isopropyl alcohol concentration was observed on 
percent entrapment of ethosomes. The entrapment 
efficiency was maximum for Etho 12 (95%) and 
minimum for Etho 14 (83.8%). In formulation Etho 14 
we use 20% of ethanol and 20% of isopropyl alcohol. 
Where as formulation Etho 12 contain only isopropyl 
alcohol 40%. The entrapment efficiency increased with 
an increase in the concentration of lecithin. In 
formulation Etho 11, 2% lecithin was used the 
entrapment was (88%) and in formulation Etho 12, 3% 
lecithin was used the entrapment was (95.7%) but 
isopropyl alcohol concentration is same 40%. shown in 
the (Table 1). and bar graph (Fig 5).  When we 
compare the Etho 12, Etho 13 and Etho 14 the alcohol 
concentration is varied but the lecithin concentration is 
same. The formulation Etho 12 showed maximum 
entrapment 95% compare to Etho 13 and Etho 14, 
which showed 84% and 83.3% entrapment efficiency. 
This indicates that isopropyl alcohol has better 



























Figure 8. In-vitro drug release of aceclofenac from 
Etho 5, Etho12 and Etho14 formulations 
 
In vitro permeation study 
The composition of optimized formulation was as 
follow (1) Aceclofenac 1% (2) soya lecithin 3% (3) 
ethanol 40% (4) Propylene glycol 5% (5) water upto 
100%. Release study of different formulations was 
undertaken in a modified diffusion apparatus 
containing sigma membrane mouce skin. All the 
formulations had propylene glycol as a skin penetration 
enhancer. The drug incorporated was 200 mg; lecithin 
concentration is 2 % and ethanol concentration 40 
%.The formulation Etho 1 showed 88.88% drug release 
within 8 h. 
The in vitro drug releases of various formulations are 
shown in (graph 6) The cumulative release of the 
ethosome gel (Etho5) was 93.6% in 8 hrs, which is 
greater than that of marketed gel (Zynac gel), which 
showed 82.8% in 8 hrs. There was increase in 
cumulative amount of drug permeated at higher ethanol 
concentration upto 40 % then there was reduction in 
permeation. This was due to the disruption of lipid 
bilayer at higher ethanol concentration. Ethanol 
provides the vesicles with soft flexible characteristics, 
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which allow them to more easily penetrate into deeper 
layers of the skin. When lecithin concentration was 
increased, there was increase in drug permeation. Use 
of propylene glycol also influenced the amount of drug 
permeation. Propylene glycol also acts as permeation 
enhancer, which increases permeability of vesicle 
through biological membrane due to synergistic effect 
with ethanol on bilayer of the vesicles. (121-124) 
Formulations (Etho 7) containing 3 % lecithin and 30 
% ethanol showed 91 % drug release within 8 h. The 
release study was also carried out using mouse skin. 
The in vitro drug release of various formulations is 
shown in (graph 7). Formulation (Etho 1) containing 2 
% lecithin  and 40 % ethanol showed 72.7% drug 
release within 8 h. Formulation (Etho 5) containing 3 
% lecithin and 40 % ethanol showed 79 % drug release 
within 8 h. Formulation (Etho 7) containing 3% 
lecithin and 30% ethanol result showed 47.2%drug 
release within 8 h. This observation indicates that 
alcohol is important for penetration compared to 
lecithin concentration. Such an observation was not 
seen in commercial sigma membrane. Since the mouse 
skin is a biological membrane consisting of lipid 

































Figure 9. Permeation parameter of aceclofenac via 
different formulation  
 
Ethanol provides the vesicles with soft flexible 
characteristic, which allow them to more easily 
penetrate into deeper layers of the skin. When 
ethosomal carriers, which contain ethanol, and soft 
small vesicles are applied to the skin a number of 
concomitant processes may take place, involving the 
stratum corneum and pilosebaceous pathway. Evidence 
of existence of the follicular transport pathway taken 
by the lipid vesicles have been reported [7-17]. first, 
ethanol disturbs the organization of the stratum 
corneum lipid bilayer and enhances its lipid fluidity. 
The flexible ethosome vesicles can then penetrate the 
disturbed SC bilayers and even forge a pathway 
through the skin by virtue of the particulate nature. The 
release of the drug in deep layer of the skin and its 
transdermal absorption could then be the result of 
fusion of ethosome with skin lipid and drug release at 
various points along the penetration pathway [9]. 
The in vitro drug release of various formulations is 
shown in (graph 8) Formulation (Etho 12) containing 3 
% lecithin and 40 % isopropyl alcohol  showed 83.2% 
drug release in 8 h. whereas formulation (Etho 14) 
containing 3 % lecithin, 20 % ethanol and 20 % 
isopropyl alcohol showed 85.4 % drug release within 8 
h. When we compare formulation Etho 5,12 and 14. 
Formulation Etho 5 showed higher release than that of 
Etho 12 and Etho 14.When we consider the amount of 
drug released from formulation Etho 12, 14, 
formulation Etho 14 released higher (85.4%) as 
compared to formulation Etho 12 (83.2%). This 
indicates that isopropyl alcohol does not promote better 
release as ethyl alcohol. The incorporation of ethyl 
alcohol in formulation Etho 14 (50%) slightly 
increased the release. This is further supported by 
comparison of formulation Etho 5 and Etho 12. 
Formulation Etho 5 contains ethyl alcohol and 
formulation Etho 12 contains isopropyl alcohol. The 
release of Etho 5 is 93% and Etho 12 is 83.2%. Hence 
we can conclude that isopropyl alcohol has poor 
influence on release.  
The values of different ethosomal formulation were 
observed between 116.5 µg/cm²/hr to 226.1 µg/cm²/hr. 
Formulation (Etho 5) shows maximum J value 226.1 
µg/cm²/hr as compared to marketed one 131.1 
µg/cm²/hr. The data also suggested that the value of 
flux also depends on the ethanol concentration. As the 
concentration of ethanol increased, flux value of 
aceclofenac increased. Because in formulation Etho 5 
ethanol concentration is 40 % and in formulation Etho 
7 ethanol concentration is 30 %. 
Formulation (Etho 12) shows J value 159.0 µg/cm²/hr. 
Formulation (Etho 14) which is the combination of 
(20% IPA+ 20% Ethanol) shows J value 146.0 
µg/cm²/hr. All the formulation shows higher J value 
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compared to marketed one The transdermal flux of 
aceclofenac was also carried out using mouse skin. 
Formulation Etho 5 (171.0 µg/cm²/hr) shows higher J 
value then the marketed one (131.1 µg/cm²/hr).The 
data also suggested that the value of flux also depends 
on the ethanol concentration. As the concentration of 
ethanol increased, flux value of aceclofenac increased. 
Formulation Etho 5 and Etho 1 containing same 
percent of ethanol 40% whereas compare to 
formulation Etho 7 containing 30% ethanol. These 
result further supported by the observation of 
zidovudine-loaded ethosome made by Jain et al (2004). 
The data suggested transdermal flux of zidovudine 
increased with increase in ethanol concentration. The 
effect on ethanol on stratum corneum lipids and on 
vesicle fluidity as well as a dynamic interaction 
between ethosomes and the stratum corneum all may 
contribute to the superior skin penetration ability of 
ethosomes [9-12]. 
 
Table 3. Stability studies date of aceclofenac 
 
Time       
( days) 
Percent entrapment      
(4 ± 2°C) 
Percent entrapment  
( RT) 
1 91.1±0.8 91.1±0.8 
15 91.1±0.5 90.8±0.2 
30 90.4±0.6 89.2±0.4 
45 89.9±0.6 88.9±08 
Mean ± SD, n = 3, RT = Room temperature 
Analysis of drug release mechanism 
When the data was plotted as cumulative percentage of 
drug permeated versus time, the profile show that the 
gel releases the drug rapidly in the initial hours 
followed by the slow release in the next hours. The 
graph show that the profiles did not match zero order 
release parttern. Hence the data was subjected to first 
order equation and the line were not linear (R² = 0.671 
– 0.9047). further to find out whether diffusion is 
involved in the drug release, the data was subjected to 
Higuchi’s equation the line obtained comparatively 
more linear (R² = 0.9464 – 0.991). To confirm further 
release mechanism of drug, the data was subjected to 
Korsmeyer’s equation. (R² = 0.9638 – 0.989). As done 
in the previous experiment, the drug permeation data 
was plotted according to first order, Higuchi’s and 
Korsmeyer’s equation to know the release mechanisms. 
The formulation was not shown fair linearity with 
respect to first order (R² = 0.4554 – 0.6396) and 
Higuchi’s equation (R² = 0.9684 – 0.9933) and 
Korsmeyer’s equation (R² = 0.4717 – 0.5629) these 
data showed that the previous results showed linear line 
compare to skin release. The observation confirmed 
that diffusion is dominant mechanism for drug release. 
 
Stability study 
The ability of vesicles to retain the drug was assessed 
by keeping the ethosomal suspension at different 
temperature. Optimized ethosome formulation (Etho 5) 
was selected for stability studies of vesicles. The 
vesicular suspension was kept in sealed vials (10ml) at 
4 ± 2ºC and at room temperature for 45 days. Percent 
entrapment was determined at different time intervals. 
It was observed that the ethosomal system was more 
stable at 4 ± 2°C showed in (table 3). 
 
Conclusion 
The aim of the current investigation is to evaluate the 
transdermal potential of novel vesicular carrier, 
ethosomes, bearing aceclofenac, Non-steroidal anti-
inflammatory drugs (NSAIDs) agents having limited 
transdermal permeation. The result advocates the 
potential of ethosome formulation to treat rheumatic 
disease where facilitated penetration of the drug into 
muscle and synovial fluid is desirable. In light of the 
data obtained from experimental work we can expect 
the ethosome formulation to be safe and very efficient 
as a drug carrier for systemic as well as topical delivery 
of drug, holding future in effective transdermal 
delivery. Ethosome has proven to be superior even to 
the marketed gel for the topical administration. Further, 
these finding may help the industry for development 
and scaling up a new formulation. 
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